Y. Xu

The function of src family tyrosine kinases in hematopoietic cells.

J. Potter, Y. Xu, C. Willman, 1996, Leukemia research.

Inhibition of beta 2 integrin receptor and Syk kinase signaling in monocytes by the Src family kinase Fgr.

H. Gresham, C. Willman, R. Geahlen, 2001, Immunity.

HH-GV-678, a novel selective inhibitor of Bcr-Abl, outperforms imatinib and effectively overrides imatinib resistance

L. Lou, H. Quan, L. Fu, 2010, Leukemia.

SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in models of FLT3-driven AML and considerable potency in models of CML harboring Abl mutants

L. Zhong, R. Zheng, Z. Cao, 2012, Leukemia.